Search research articles
Contact Us
Filters
Showing results (221-230 of 319) with videos related to
Page
of 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Ali Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
British Journal of Haematology
|
October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus
Sylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
The Journal of Infection
|
July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
Sina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Transplantation and Cellular Therapy
|
July 28, 2024
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Zinaida Peric, et al.
Leukemia
|
December 16, 2015
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)
E Schuler, A Giagounidis, D Haase, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Bone Marrow Transplantation
|
March 6, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party
Gesine Bug, Myriam Labopin, Jennifer L Byrne, et al.
British Journal of Haematology
|
November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 319) with videos related to
Sort By:
Page
of 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Ali Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
British Journal of Haematology
|
October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus
Sylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
The Journal of Infection
|
July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
Sina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Transplantation and Cellular Therapy
|
July 28, 2024
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Zinaida Peric, et al.
Leukemia
|
December 16, 2015
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)
E Schuler, A Giagounidis, D Haase, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Bone Marrow Transplantation
|
March 6, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party
Gesine Bug, Myriam Labopin, Jennifer L Byrne, et al.
British Journal of Haematology
|
November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Page
of 32